APA Alıntı

Strzebonska, K., Wasylewski, M. T., Zaborowska, L., Polak, M., Slugocka, E., Stras, J., . . . Waligora, M. (2021). Risk and Benefit for Targeted Therapy Agents in Pediatric Phase II Trials in Oncology: A Systematic Review with a Meta-Analysis. Target Oncol.

Chicago Stili Alıntı

Strzebonska, Karolina, Mateusz T. Wasylewski, Lucja Zaborowska, Maciej Polak, Emilia Slugocka, Jakub Stras, Mateusz Blukacz, Bishal Gyawali, ve Marcin Waligora. "Risk and Benefit for Targeted Therapy Agents in Pediatric Phase II Trials in Oncology: A Systematic Review With a Meta-Analysis." Target Oncol 2021.

MLA Alıntı

Strzebonska, Karolina, et al. "Risk and Benefit for Targeted Therapy Agents in Pediatric Phase II Trials in Oncology: A Systematic Review With a Meta-Analysis." Target Oncol 2021.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..